Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

About the Company

[Summary] 小分子新药研发商

成都奥睿药业有限公司于2020年7月成立,位于成都前沿医学中心,是一家创新的研发驱动型生物制药公司。奥睿药业专注于肿瘤、免疫等重大疾病领域的小分子新药研发,目前自主研发的新药产品均为原创的全球新药,以满足中国及全球患者的重大未被满足的临床需求,具有充分的技术优势和巨大的市场空间。

     奥睿药业拥有一支具备国际视野和创新能力的优秀团队,核心管理及研发人员均具备数十年新药研发及管理经验,具备大型制药企业、CRO机构、科研机构和医药投资机构工作背景,曾领导和参与多个原创新药研发,并推动数个候选新药进入临床试验阶段。公司已初步建成符合国际标准的新药研发实验室,配备完善的高端实验设备,覆盖靶点验证、药物发现及优化、临床前研究等新药研发的关键环节,并且与国内外顶尖的CRO、CMO、高校、科研院所和医院建立了合作关系,为实现持续的科学创新提供良好保障。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

奥睿药业 Financing History (3 rounds)

Manage
A轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 融资金额未公开
  • Investor: 深圳担保,知名制药企业,中...

奥睿药业 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

奥睿药业 Related Industry Tags

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 5,417.6136万(元)
Legal Representative: 游雪丹
Date Established:
Credit Code: 91510100MA6525TW31
Registered Address: 中国(四川)自由贸易试验区成都高新区和民街16号2号楼9层901、902号,10层1001、1002号

People who follow 奥睿药业 also follow

奥睿药业 Competitors (Similar Companies)

“重庆市重点医药企业”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates